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Abstract. 
 
Physical training regulates muscle metabolic 
and contractile properties by altering gene expression. 
Electrical activity evoked in muscle ﬁber membrane 
during physical activity is crucial for such regulation, 
but the subsequent intracellular pathway is virtually un-
mapped. Here we investigate the ability of myogenin, a 
muscle-speciﬁc transcription factor strongly regulated 
by electrical activity, to alter muscle phenotype. Myoge-
nin was overexpressed in transgenic mice using regula-
tory elements that confer strong expression conﬁned to 
differentiated post-mitotic fast muscle ﬁbers. In fast 
muscles from such mice, the activity levels of oxidative 
mitochondrial enzymes were elevated two- to three-
fold, whereas levels of glycolytic enzymes were reduced 
to levels 0.3–0.6 times those found in wild-type mice. 
Histochemical analysis shows widespread increases in 
mitochondrial components and glycogen accumulation. 
The changes in enzyme content were accompanied by a 
reduction in ﬁber size, such that many ﬁbers acquired a 
size typical of oxidative ﬁbers. No change in ﬁber type-
speciﬁc myosin heavy chain isoform expression was
observed. Changes in metabolic properties without 
changes in myosins are observed after moderate endur-
ance training in mammals, including humans. Our data 
suggest that myogenin regulated by electrical activity 
may mediate effects of physical training on metabolic 
capacity in muscle.
Key words: enzymes • exercise • gene expression reg-
ulation • mitochondria • muscle ﬁbers
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 muscle is composed of muscle fibers with
diverse functional properties optimized for different
tasks. These properties are linked to the molecular
makeup of the cells, and it has traditionally been popular
to classify muscle fibers into distinct fiber types based on
the biochemical properties of their myosin and content of
metabolic enzymes. Today, fiber types can be precisely
classified according to the myosin heavy chain (MyHC)
 
1
 
gene that is expressed. Usually, one of four major MyHC
genes are expressed in adult rodent skeletal muscle fiber,
which have been dubbed types 1, 2A, 2X (also called 2D),
and 2B (Schiaffino et al., 1989). These fiber types differ
along a continuum of contraction speed, type 1 being the
slowest and 2B the fastest. They also differ in endurance,
such that type 1 fatigues slowly and 2B rapidly. The speed
of fiber contraction is most likely dependent on MyHC
type (Reiser et al., 1985; Bottinelli et al., 1994). On the
other hand, endurance is more closely related to the ability
of the tissue to provide ATP for the actomyosin cross-
bridge cycle during contraction, and therefore is depen-
dent on the content of metabolic enzymes. Type 1 fibers
generally have high levels of oxidative enzymes providing
a slow, but stable, and long lasting supply of ATP derived
from oxidation of nutrients provided by the blood. Type
2B fibers have high levels of glycolytic enzymes providing
a rapid source of ATP independent of oxygen, but this
pathway rapidly depletes the glycogen energy stores of
type 2B fibers, and fatigue develops after brief usage.
Fully differentiated muscle fibers can undergo substan-
tial phenotypic change in order to adapt to changing de-
mands of the environment. Such changes can be quite dra-
matic, but, even so, they can occur in preexisting fibers
without prior cell death and regeneration (Gorza et al.,
1988). Thus, with some exceptions, changes in the pattern
of usage induced experimentally by electrical stimulation
through implanted electrodes can alter a muscle fiber phe-
notype from one extreme to the other, e.g., from type 2B
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1. 
 
Abbreviations used in this paper:
 
 EDL, musculus extensor digitorum
longus; 
 
MId
 
,
 
 
 
Id-1 transgene;
 
 MMg
 
, myogenin transgene; 
 
MMg 
 
1 
 
MId
 
,
double transgenic mice; MyHC, myosin heavy chain; NRF-1, nuclear res-
piratory factor 1. 
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to type 1 (Mayne et al., 1993; Windisch et al., 1998). Such
complete fiber type transformations apparently require
long periods of treatment with completely altered activity
patterns (for review see Gundersen, 1998). Thus, studies
on the effect of physical training in humans or animals
have typically led to less dramatic changes (for reviews see
Henriksson and Hickner, 1994; Fitts and Widrick, 1996).
Although changes within type 2 (e.g., from 2B to 2A) have
been described (see Abdelmalki et al., 1993; Wang et al.,
1993; Kraemer et al., 1995), training frequently induces
dramatic changes in metabolic properties without MyHC
fiber type conversion (see Kiens et al., 1993; Schluter and
Fitts, 1994).
Whereas muscle plasticity is well described at the phe-
nomenological level in a variety of experimental and train-
ing situations, little is known about the intracellular path-
ways linking demand (activity, load, etc.) to changes in
gene expression of proteins related to metabolism and
contraction. Various transcription factors are known to
regulate muscle gene expression, among them are four
muscle-specific basic helix-loop-helix proteins: MyoD,
myogenin, MRF4, and Myf5 (for reviews see Weintraub,
1993; Molkentin and Olson, 1996). These factors were
originally isolated as key regulatory molecules in early
muscle differentiation, but expression continues in mature
muscle tissue of adult animals, suggesting that they may
play a more extended role. In particular, it has been postu-
lated that they provide a link between electrical activity
and gene regulation. Thus, upon paralysis, the levels of
mRNA for all four myogenic factors are elevated (Duclert
et al., 1991; Eftimie et al., 1991; Witzemann and Sakmann,
1991; Buonanno et al., 1992; Neville et al., 1992; Merlie
et al., 1994), and this elevation is thought to take part in
the development of acetylcholine supersensitivity (Piette
et al., 1990; Gilmour et al., 1991; Jia et al., 1992; Prody and
Merlie, 1992; Simon and Burden, 1993; Dürr et al., 1994;
Gundersen et al., 1995). The helix-loop-helix superfamily
has also been implicated in maintenance of mature inner-
vated muscle fiber character, as the negative regulator of
helix-loop-helix proteins, Id-1, causes atrophy of fibers in
which it is overexpressed (Gundersen and Merlie, 1994).
Furthermore, the level of myogenic factors differs be-
tween MyHC fiber types, and changes in the level parallel
MyHC fiber type conversion (Hughes et al., 1993b; Voytik
et al., 1993). In particular, subtle shifts in MyHC fiber type
detected in mice lacking a functional MyoD gene have
raised the possibility that myogenic factors might contrib-
ute to the control of the properties of specific adult fiber
types (Hughes et al., 1997).
In the present study, we show that overexpression of the
transcription factor myogenin in muscle cells of transgenic
mice induced a shift in metabolic enzyme content, such
that levels of oxidative enzymes were increased while gly-
colytic enzymes were reduced. This shift in the slow direc-
tion occurred without detectable changes in MyHC fiber
type.
 
Materials and Methods
 
Transgenic Animals
 
To overexpress myogenin and Id-1 in differentiated muscle cells the myo-
 
genin (
 
MMg
 
) and Id-1 (
 
MId
 
) transgenes were inserted into the genome of
mice by conventional transgenic techniques described previously (Gun-
dersen et al., 1993, 1995; Gundersen and Merlie, 1994). In brief, the 
 
MMg
 
transgene contains rat myogenin cDNA (Wright et al., 1989) and the 
 
MId
 
transgene contains mouse Id-1 cDNA (Benezra et al., 1990). Both trans-
genes are driven by the myosin light chain 1 promoter and 3
 
9
 
 1/3 enhancer,
which have been shown to confer expression only in differentiated post-
mitotic muscle fibers (Rosenthal et al., 1989). Moreover, the expression is
fiber type-dependent, such that the level of expression declines in the or-
der 2B 
 
. 
 
2X 
 
. 
 
2A 
 
. 
 
1 (Donoghue et al., 1991). Animals containing the
 
MMg
 
 transgene have a high neonatal lethality, whereas bearers of the
 
MId
 
 transgene have the same survival rate as nontransgenic littermates.
The 
 
MId
 
 transgene can overcome the deleterious effect of the 
 
MMg
 
 trans-
gene such that bearers of both transgenes (
 
MMg 
 
1 
 
MId
 
) have normal
survival rates (Gundersen et al., 1995). Thus, we propagate the 
 
MMg
 
 trans-
gene in double transgenic mice (
 
MMg 
 
1 
 
MId
 
), which are mated to wild-
type mice to yield offspring of the following four genotypes identified by
PCR analysis (Hanley and Merlie, 1991):
 
 MMg
 
,
 
 MId
 
,
 
 MMg 
 
1 
 
MId
 
, and
wild-type. The wild-type littermates served as controls in the present study
(for further detail see Gundersen et al., 1995). In all cases the analyzed
muscles were from mice that were 2–6-mo old.
 
RNA and Western Analysis
 
RNA was extracted as described by Chomczynski and Sacchi (1987), and
the level of rat myogenin mRNA from the transgene was determined by
RNase protection assays as described by Melton
 
 
 
et al. (1984). The speci-
ficities of the protected bands were determined by hybridization against
equal amounts of yeast tRNA. For further details see Gundersen et al.
(1995).
Protein extracts were prepared in 50 mM Tris-HCl, pH 7.4, 0.6 M NaCl,
5 mM EDTA, 10% SDS, 1 
 
m
 
g/ml pepstatin A, 0.1% PMSF, 1% 
 
b
 
-mercap-
toethanol by homogenization in volumes normalized for wet weight of
tissue. After separation on 12.5% SDS-PAGE, electroblotting to Amer-
sham Hybond-C super filters, and blocking with 3% Tween 20, 5% horse
serum in PBS, proteins were reacted with 1:70 diluted primary mono-
clonal tissue culture supernatants in 0.5% Tween 20, PBS. Detection was
with 1:1,500 HRP-conjugated rabbit anti–mouse Ig (Dako Corp.) followed
by the ECL kit.
 
Enzyme Analysis
 
Mice were anesthetized by ether, single muscles were dissected out, and
snap frozen in liquid nitrogen. Muscle samples were homogenized directly
from frozen in a stabilizing medium containing 50% glycerol, 20 mM
phosphate buffer, pH 7.4, 5 mM 
 
b
 
-mercaptoethanol, 0.5 mM EDTA,
0.02% BSA at a dilution of 1:100 based on wet weight. All assays for a
particular enzyme were performed on the same day, over a 60-min incuba-
tion period at 25
 
8
 
C. Activities are given as mol 
 
?
 
 
 
kg wet wt
 
2
 
1
 
h
 
2
 
1
 
. Final
readings were made fluorometrically in a vol of 1 ml. Standards were car-
ried through the entire procedure. Detailed protocols for analyzing the ac-
tivity of each of the enzymes were published previously (Lowry et al.,
1978; Chi et al., 1983, 1986; Henriksson et al., 1986).
 
Enzyme and Immunohistochemistry
 
Individual mouse muscles were dissected from hindlimbs, mounted in
OCT, frozen in freezing isopentane, and 10–15 
 
m
 
m cryostat sections were
cut from the midbelly region, mounted on gelatin coated glass slides, and
stained as described by Dubowitz (1985) for either: periodic acid-Schiff to
reveal glycogen content, NADH-tetrazolium reductase to show mitochon-
drial complex I content, or succinate dehydrogenase to determine mito-
chondrial complex II content. For immunohistochemistry, sections were
stained as in Hughes et al. (1993a) using Vector biotin-conjugated class-
specific secondary antibodies and the Vectastain ABC kit. HRP was de-
tected with diaminobenzidine and cobalt enhancement. Serial cryosec-
tions were exposed to mAbs that recognize epitopes on distinct MyHC
isoforms. A4.951 and A4.840 were used to detect slow MyHC, A4.74 to
detect type 2A MyHC, and N2.261 to detect both slow and 2A MyHC
(Hughes et al., 1993a). To distinguish developmental isoforms of fast
MyHCs F1.652 (embryonic), N3.36, A4.1519 and N1.551 (staining subsets
of neonatal and type 2), BF-F3 (adult 2B) and BF35 (all non-type 2X)
were employed (Schiaffino et al., 1989; Cho et al., 1994). Analysis and photog-
raphy were performed on a Zeiss Axiophot using Normarski optics. Fiber
numbers (see Table II) were determined by scoring each fiber in the full
cross section of the muscle as either positive or negative for each anti- 
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body. Thus, 300–500 soleus fibers and 
 
z
 
1,000 extensor digitorum longus
(EDL) fibers were scored in each leg.
 
Fiber Size Analysis
 
Cross section images close to the midbelly of EDL muscles that had been
stained for NADH-tetrazolium reductase were captured on a Macintosh
computer and analyzed with NIH Image. Sections were only included in
the analysis if fiber major axes showed near random orientation, indicat-
ing they were cut close to transversely. Several hundred fibers in each
muscle were outlined with the mouse and their parameters (including
staining pattern, area, and axis orientation) were recorded. Mean fiber ar-
eas were calculated for each fiber type in each muscle. Average fiber size
from groups of the same genotype was determined by a weighted average
of these means. However, to test accurately for statistically significant dif-
ferences, an ANOVA test was performed, using Mathematica (Dunn et al.,
1997).
 
Results
 
Metabolic Profile of Fast and Slow Wild-Type Muscles
 
Mouse strains have been shown to differ in fiber type con-
tent, so we first determined the activity of ten enzymes in
three different muscles, plantaris, tibialis anterior, and so-
leus, in wild-type mice of similar genetic background to
the transgenic animal. AK (see Table I for full enzyme
names) is a mitochondrial enzyme involved in high energy
phosphate transfer and we found no significant difference
between fast and slow muscles (Table I). HK, PHRL,
GOPDH, PK, and LDH are enzymes catalyzing individual
steps in glycolysis. With the exception of HK, these en-
zymes had highest activity in the fast glycolytic plantaris
muscle, and lowest in the slow oxidative soleus (Table I).
HK is known to be high in slow muscles (Chi et al., 1992)
and this was confirmed in the present study (Table I). In
contrast, Thiol, BOAC, Cit Syn, and MDH are all en-
zymes that take part in oxidative energy production, and
these were all highest in the oxidative soleus and lowest in
the glycolytic plantaris muscles (Table I). The ratio of the
activity of each enzyme in the slow soleus to the fast plan-
taris varied between 0.2 and 0.5 for the glycolytic enzymes
(excluding HK), and between 2 and 3 for the oxidative en-
zymes. These values are illustrated in Fig. 1 which shows
the enzyme profile of the slow soleus compared with the
fast plantaris. It is evident, and this is in agreement with
previous studies, that glycolytic enzyme activities in our
nontransgenic mice are higher in fast muscles than in slow
muscles, while the opposite is the case for oxidative en-
zymes.
 
Myogenin Expression in Transgenic Mice
 
To determine the role of myogenin in adult muscle fibers,
we examined 
 
MMg
 
 transgenic mice in which myogenin
cDNA is expressed from the myosin light chain 1 pro-
moter and 3
 
9
 
 1/3 enhancer (Rosenthal et al., 1989). The
level of transgenic rat mRNA in the mice was previously
reported to be 100-fold of the endogenous form (Gunder-
sen et al., 1995). We confirm by RNase protection that
muscle RNA from the 
 
MMg
 
 mice and 
 
MMg 
 
1 
 
MId 
 
mice
hybridized strongly with rat mRNA sequence, while RNA
from 
 
MId
 
 and wild-type mice was below the detection
limit (Fig. 2). To demonstrate that myogenin protein is ac-
cumulated from the transgene, we performed Western
analysis on extracts of adult transgenic and wild-type lit-
termate thigh muscle (Fig. 2). While no myogenin was de-
tectable in wild-type muscle extract, in 
 
MMg
 
 muscle ex-
tract a band was readily detected of 
 
z
 
32,000 
 
M
 
r
 
, the
reported size of myogenin protein (Li et al., 1992). No ab-
errant sized bands were observed to differ between 
 
MMg
 
and wild-type animals. We confirmed the transgene-speci-
ficity of the 32,000-
 
M
 
r
 
 band by analyzing mice that carried
 
MMg
 
 on the 
 
MId
 
 transgenic background. Whereas the
 
MId
 
 mouse did not contain detectable myogenin immu-
 
Table I. Enzyme Activity in Muscles of Wild-Type Mice (mol 
 
? 
 
kg
 
2
 
1
 
h
 
2
 
1
 
)
 
Enzyme Muscle
Code no. Full name Function Acronym Plantaris Tibialis anterior Soleus
 
EC2.7.4.3 Adenylate kinase Purine salvage AK 289.5 
 
6
 
 26.5 286.6 
 
6
 
 13.2 230.4 
 
6
 
 4.6
EC2.7.1.1 Hexokinase Glycolysis HK 2.2 
 
6
 
 0.4 2.7 
 
6
 
 0.6 2.4 
 
6
 
 0.1
EC2.4.1.1 Glycogen phosphorylase Glycogen degradation PHRL 14.2 
 
6
 
 1.0 11.2 
 
6
 
 0.4 4.1 
 
6
 
 0.4
EC1.1.1.8 Glycerol-3-phosphate dehydrogenase (NAD
 
1
 
) Glycolysis GOPDH 10.7 
 
6
 
 0.9 10.9 
 
6
 
 1.8 2.1 
 
6
 
 0.3
EC2.7.1.40 Pyruvate kinase Glycolysis PK 91.3 
 
6
 
 4.5 91.7 
 
6
 
 3.4 37.4 
 
6
 
 3.2
EC1.1.1.27 Lactate dehydrogenase Glycolysis LDH 174.3 
 
6
 
 7.5 167.1 
 
6
 
 12.1 61.8 
 
6
 
 2.9
EC2.3.1.9 Acetoacetyl-CoA thiolase Fatty acid degradation Thiol 2.5 
 
6
 
 0.5 3.3 
 
6
 
 0.3 5.1 
 
6
 
 0.4
EC1.1.1.35
 
b
 
-hydroxyacyl-CoA dehydrogenase Fatty acid degradation BOAC 9.3 
 
6
 
 1.6 12.1 
 
6
 
 2.1 15.2 
 
6
 
 0.6
EC4.1.3.7 Citrate (si)-synthase Tricarboxylic acid cycle Cit Syn 1.3 
 
6
 
 0.3 1.6 
 
6
 
 0.4 2.7 
 
6
 
 0.4
EC1.1.1.37 Malate dehydrogenase Tricarboxylic acid cycle MDH 25.5 
 
6
 
 3.3 30.0 
 
6
 
 3.4 35.0 
 
6
 
 1.2
 
Data given as mean 
 
6
 
 SEM of four muscles.
Figure 1. Fast muscle has
higher glycolytic and lower
oxidative enzyme activity
than slow muscle. Enzyme
activity in four wild-type so-
leus muscles was determined
and divided by the mean
value for each enzyme in the
wild-type plantaris (Table I).
Values are given as mean 6
SEM on a logarithmic scale.
*Significant differences be-
tween soleus and plantaris
(two-tailed  t test, P # 0.05).
The full names of the en-
zymes are given in Table I. 
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noreactivity, the 
 
MMg 
 
1 
 
MId
 
 double transgenic animal
showed higher myogenin immunoreactivity than the 
 
MMg
 
animal (Fig. 2). Attempts to visualize myogenin protein in
tissue sections of wild-type, 
 
MMg
 
, 
 
MId
 
, or 
 
MMg 
 
1 
 
MId
 
mice were not successful, despite use of three distinct
mAbs to different epitopes, including the F5D reagent em-
ployed in the Western analysis. It is possible that in vivo
adult muscle myogenin may be present in an immunologi-
cally unreactive form. Nevertheless, the 
 
MMg
 
 transgene
causes accumulation of a protein with immunoreactivity
and size typical of myogenin in the predominantly fast
thigh muscle of adult mice.
 
Myogenin Induces a Shift towards
Oxidative Metabolism
 
As the 
 
MMg
 
 transgene is expected to be expressed pre-
dominantly in fast muscles (Donoghue et al., 1991), we
first investigated the fast white plantaris muscle of adult
 
MMg
 
 mice. When this and other fast muscles were in-
spected macroscopically, they appeared more red than in
wild-type mice, suggesting a higher myoglobin content, a
classical sign of a change in fiber type (Ranviér, 1874). The
levels of the oxidative enzymes Thiol, BOAC, Cit Syn, and
MDH were 6.1 
 
6 
 
0.1, 25.0 
 
6 
 
1.9, 4.3 
 
6 
 
0.1, and 40.2 
 
6 
 
0.1
(two muscles, mean 
 
6
 
 SEM, mol 
 
?
 
 kg
 
2
 
1
 
h21), respectively.
This represents a two- to threefold increase compared
with levels found in plantaris muscles of wild-type litter-
mate mice (Fig. 3, upper panel). The activity levels of the
glycolytic enzymes HK, PHRL, GOPDH, PK, and LDH
were 2.8 6 0.0, 7.8 6 0.26, 3.4 6 0.4, 55.9 6 1.5, and 85.5 6
0.9, respectively. This represents reductions to levels 0.3–
0.6 times the levels in wild-type, with the exception that
the glycolytic HK was not significantly changed (Fig. 3, up-
per panel). Thus, the plantaris muscle of the MMg mice
had a changed enzyme profile from one typical of a fast
muscle to one typical of a slow muscle. This is most evi-
dent by comparing the profiles in Fig. 1 and the upper
panel of Fig. 3, which are remarkably similar. In quantita-
tive terms, MMg plantaris muscles had even higher oxida-
tive enzyme activities than those found in the soleus, but
the glycolytic enzymes were not reduced to levels quite as
low as in the wild-type soleus. Similar comparisons were
made for the fast tibialis anterior muscle (Fig. 3, middle
panel). Again, all the oxidative enzymes were significantly
increased. The effect on glycolytic enzymes was less pro-
nounced, but the tibialis anterior showed a tendency to-
wards an increase in glycolytic activity.
The mouse soleus contains a mixture of type 1 and 2A
fibers with no 2B fibers, and very few 2X fibers (see below,
and Schmalbruch, 1985). Although the MMg transgene
expression would be expected to be relatively low in this
muscle, several of the oxidative enzymes showed signifi-
cantly increased activity (Fig. 3, lower panel). There were
no significant changes in glycolytic enzymes (Fig. 3, lower
panel), but these enzymes are already low in the wild-type
soleus.
We have previously reported that z90% of the myoge-
nin overexpressing mice died during the first few days af-
ter birth (Gundersen et al., 1995). The effect was probably
not insertion specific. A pathological evaluation revealed
nothing unusual in the neonates, but since the regulatory
Figure 2. The myogenin
transgene produces mRNA
and protein as shown by
RNase protection and West-
ern blotting. In the RNA
protection assay, thigh
muscle  RNA extracts were
hybridized against a rat myo-
genin cDNA template con-
taining the sequence be-
tween the StuI site at base
398 of the coding sequence
and a StyI site 31 bases into
the 39 noncoding sequence
protecting 495 bases of the
mRNA. In the Western blot
thigh muscle, protein ex-
tracts were analyzed using
antibody F5D that recognizes murine myogenin (Wright et al.,
1991). Weak background bands are detected at several positions
in all lanes containing muscle protein. In parallel experiments,
these bands, but not the band at 32,000 Mr, were also detected by
a control antibody of the same subclass (IgG1) directed against
embryonic MyHC, although no genuine embryonic MyHC was
observed at 220,000 Mr. Equal protein loading was demonstrated
by Coomassie blue staining, which showed no detectable differ-
ence between the four samples in the proteins z32,000 Mr. Val-
ues at left are Mr 3 1023.
Figure 3. Myogenin overex-
pression causes a shift from
glycolytic to oxidative metab-
olism. Enzyme activity in
plantaris, tibialis anterior,
and soleus muscles from
MMg transgenic mice was de-
termined and divided by the
mean value for each enzyme
found in the same wild-type
muscles (Table I). Values are
given as mean 6 SEM on a
logarithmic scale. *Signifi-
cant differences between
transgenic and wild-type
muscles (two-tailed t test,
P  # 0.05). The full names of
the enzymes are given in Ta-
ble I. Note the similarity be-
tween the upper panel and
Fig. 1.Hughes et al. Myogenin and Muscle Metabolism 637
regions in the transgene confer expression only in muscle,
it was suggested that the deaths were caused by some sub-
tle muscle pathology (Gundersen et al., 1995). As we are
dealing with outbred mice, this raised the possibility that
the different enzyme levels observed in surviving adult
MMg mice were caused by selection rather than specific
effects of overexpressing myogenin. Therefore, we investi-
gated the effects of overexpressing myogenin in animals
that had no increased lethality. This was achieved by cross-
breeding the MMg animals with transgenic MId animals
overexpressing the negative regulator Id-1 (see Materials
and Methods; Gundersen et al., 1995). After determining
that the MId transgene itself had minimal effects on en-
zyme levels (Fig. 4, left panels), enzyme activity was inves-
tigated in animals having both transgenes (MMg 1 MId).
These mice had enzyme levels similar to those found in
muscles containing only the MMg transgene (Fig. 4, right
panels). In the MMg 1 MId mice, the effect of myogenin
overexpression cannot be attributed to selection since the
doubly transgenic animals had no increased neonatal le-
thality (Gundersen et al., 1995). Thus, in all muscles exam-
ined, the MMg transgene caused a shift towards oxidative
character.
To analyze the changes in metabolic properties of MMg
and MMg 1 MId muscles in greater detail, we employed
enzyme histochemistry on tissue sections. Although this
approach is nonquantitative, it has the advantage of re-
vealing which muscle fibers are altered by the transgene.
We examined the well-defined fast EDL muscle, and ob-
served dramatic changes in metabolic properties of a sub-
population of fibers in the presence of the MMg transgene
(Fig. 5). Fast glycolytic type 2B fibers became oxidative,
whereas no change was detected in oxidative type 2A fi-
bers. In wild-type mice, the smallest type 2A oxidative fi-
bers generally contain little cytoplasmic glycogen (Fig. 5
A, arrows). In MMg mice, glycogen content of such fibers
remained low, consistent with the predicted low level of
expression of the transgene in these fibers. In contrast, in
wild-type mice the large fast fibers, almost all of which ex-
press type 2B or 2X MyHC, fell into two groups: one
group that had low levels of glycogen, and another group
of slightly smaller size that contained higher levels of gly-
cogen (Fig. 5 A). In MMg mice, the overall number of gly-
cogen-rich fibers was greatly increased, so that fibers in
both groups must have raised glycogen content, compared
with wild-type littermates (Fig. 5, A and B).
In parallel with the alteration in cytoplasmic glycogen
content of the fastest fibers, there was a change in mito-
chondrial enzyme activities, which are normally highest
in mitochondria-rich oxidative fiber types. NADH-tetra-
zolium reductase and SDH are part of the mitochondrial
electron transport chain. The activities of both enzymes
were markedly increased in type 2B/2X fibers of MMg
EDL, compared with the wild-type (Fig. 5, E, F, I, and J).
In contrast, the high mitochondrial enzyme activity
of type 2A fibers remained unchanged. Thus, the change
in mitochondrial enzyme activity detected in whole mus-
cle homogenates could also be detected at the single fi-
ber level. Therefore, fibers expressing distinct MyHC
isoforms and with distinct glycogen content could not
be distinguished by mitochondrial enzymes in the
MMg EDL.
The fastest classes of fibers showed the greatest change
in MMg mice. Similar changes were also observed in MMg 1
MId mice, but not in control animals carrying the MId
transgene alone, in which fiber type heterogeneity in met-
abolic properties was clearly detectable and similar to
wild-type mice (Fig. 5). Analysis of several animals of each
genotype gave similar results. However, the phenotype in
MMg 1 MId mice appeared more variable than that of
MMg mice. The vast majority of the 2B fibers of all pure
MMg animals reacted more strongly than did normal 2B
fibers when stained for glycogen, SDH, or NADH-tetrazo-
lium reductase. Two out of the four MMg 1 MId animals
analyzed displayed a similar histochemical picture, but in
two other animals the 2B fibers were less affected, and a
significant number of the fibers were no different from 2B
fibers in wild-type mice.
Figure 4. Rescue of MMg mice with the MId transgene does not
prevent metabolic changes. Enzyme activity in plantaris, tibialis
anterior, and soleus muscles from MId transgenic mice (left) or in
MMg 1 MId transgenic mice (right) was determined and divided
by the mean value for each enzyme found in wild-type muscles
(Table I). Values are given as mean 6 SEM on a logarithmic
scale. *Significant differences between transgenic and wild-type
muscles (two-tailed t test, P # 0.05). The full names of the en-
zymes are given in Table I.The Journal of Cell Biology, Volume 145, 1999 638
Increased Oxidative Capacity Is Accompanied by 
Reduced Fiber Size
In wild-type mice, type 1 and 2A oxidative fibers normally
have lower cross sectional area than glycolytic 2B fibers.
Small fiber size in oxidative fibers aids rapid diffusion of
oxygen from the surrounding capillaries into the fiber inte-
rior core. In MMg mice, in which all fibers are essentially
oxidative, the size was much more uniform, and in particu-
lar, the 2B fibers were much smaller than in the wild-type
(Figs. 5 and 6; Table II). The mean area of this fiber type
was depressed almost 50%, and the maximal 2B fiber cross
sectional area was reduced from 2,500 mm2 in wild-type to
1,300 mm2 in MMg mice. In wild-type animals, the z50%
of fibers with low mitochondrial content tended to have
areas of z1,500 mm2, and the other 50% of mitochondria-
rich fibers had areas of z800 mm2. In contrast, in MMg
mice the average area of all fibers (essentially all of
which are mitochondria-rich) was significantly reduced to
z800 mm2.
Massive disappearance of mitochondria-poor fibers in
wild-type animals could have contributed to the observed
results. However, the total number of fibers in four EDL
muscles from wild-type mice was 1,071 6 250 (SD),
whereas four EDLs from MMg mice contained 844 6 151
fibers. This potential small difference was not significant (t
test) and could not account for the wholesale metabolic fi-
ber type conversion observed in the MMg mice.
Fiber area was also reduced in MMg 1 MId mice.
Moreover, even the residual 25% of mitochondria-poor fi-
bers in some of these animals was significantly reduced in
size to z840 mm2. However, as we reported previously,
MId transgenic mice also show alterations in muscle fiber
area (Gundersen and Merlie, 1994), so it is impossible to
determine whether the reduction in area of the residual
glycolytic fibers in MMg 1 MId mice is due to the MMg
or the MId transgene. Nonetheless, we conclude that
when the MMg transgene acts alone it causes the large
glycolytic 2B fibers normally present in EDL to acquire a
size comparable to the smaller oxidative fiber types. This
Figure 5. MMg transgene in-
duces increased mitochon-
drial enzymes and glycogen.
Serial sections of EDL mus-
cles of wild-type, MMg,
MMg 1 MId, or MId z120 d
female mice were reacted for
glycogen, NADH tetrazo-
lium reductase, and succi-
nate dehydrogenase. Arrows
indicate fibers expressing
type 2A MyHC, determined
by comparison with adjacent
sections. Bar, 100 mm.
Figure 6. MyHC fiber type is unaffected in MMg mice. Serial
sections of EDL (A–F) and soleus (G–L) muscles of wild-type
(A–C, G–I) or MMg (D–F, J–L) z120 d female mice were
stained for A4.951 (slow; A, D, G, and J), A4.74 (2A; B, E, H,
and K) and BF-F3 (2B; C, F, I, and L). In both animals, the ma-
jority of fibers reacted with a single antibody, confirming that fi-
bers express predominantly a single MyHC isoform. In EDL,
rare 2A fibers (arrowhead, A–F) were interspersed with abun-
dant 2B fibers (arrows, A–F). In soleus, the 2A fibers (arrow-
head, G–L) were more abundant than in EDL, and most other fi-
bers contained slow type 1 MyHC (arrows, G–L). Note that the
apparent increase in size of 2A fibers in MMg EDL was not ob-
served in other animals, and probably reflects individual varia-
tion commonly observed. Bar, 100 mm.Hughes et al. Myogenin and Muscle Metabolism 639
change could be an adaptation to the increased oxidative
metabolism, but we cannot exclude that it might be related
to impaired growth during development.
MMg Mice Have Normal MyHC Fiber Types
Having observed changes in the size of fibers and activity
of glycolytic and oxidative metabolic enzymes typical of
fast muscles, we examined the expression of fast and slow
MyHC isoforms to determine whether these muscle prop-
erties also responded to the presence of the MMg trans-
gene. Slow soleus and fast gastrocnemius, plantaris, tibialis
anterior, and EDL muscles were dissected from MMg
transgenic and control wild-type littermates, and the pro-
portion and distribution of distinct fiber types analyzed
with antibodies to specific MyHC isoforms. Despite nor-
mal animal to animal variation, none of the investigated
muscles showed any consistent difference in the number
or distribution of MyHC examined (Fig. 6), although the
sizes of type 2B MyHC-containing fibers were reduced, as
described above (Fig. 6, C and F; Table II). In particular,
no increase in the number of A4.840 reactive slow fibers
was observed (Fig. 6, A, D, G, and J; Table III) in either
fast or slow muscle, nor was any shift in the expression of
distinct fast MyHC isoforms detected. For example, there
was no increase in the number of fibers reactive with the
A4.74 antibody for 2A MyHC usually present in oxidative
fast fibers (Fig. 6, B, E, H, and K; Table III), and no de-
crease in the number of fibers reactive with BF-F3 anti-
body for 2B MyHC normally characteristic of fast glyco-
lytic fibers (Fig. 6, C, F, I, and L; Table III). Analysis with
antibodies to embryonic MyHC (F1.652), neonatal fast
MyHC (N1.551, N3.36), and antibody BF35, thought to
detect MyHCs in all fibers except type 2X (Schiaffino et al.,
1989), showed no difference in MMg mice compared with
wild-type littermates (data not shown). Thus, MMg mice
show no alteration in fiber type composition based on ex-
pression of a wide variety of MyHC isoforms.
To rule out the possibility that selective mortality
among  MMg pups could hide differences in MyHC, we
also examined MId and MMg 1 MId for changes in fibers
expressing MyHC isoforms. Again, no differences from
control animals were observed in the proportions of fibers
of particular MyHC types (Table III). Thus, despite show-
ing a shift in the metabolic character of both fast and slow
muscles, we were unable to detect a change in MyHC ex-
pression induced by the MMg transgene.
Discussion
Overexpression of myogenin influenced the activity of
metabolic enzymes, inducing a shift from glycolytic metab-
olism to oxidative fat-using metabolism in muscles that are
normally glycolytic. This shift was accompanied by a re-
duction in glycolytic fiber size to a diameter typical of oxi-
dative fibers, an increased level of glycogen, and a redden-
ing color of white muscles which expressed the transgene
at high levels. This complex change in phenotype essen-
tially mimics the effects of endurance training on muscle
(for reviews see Holloszy, 1976, 1988; Henriksson and
Table II. MMg Transgene Causes Fast Fiber Cross Sectional Area to Decrease
Genotype Metabolic fiber type MyHC fiber type
All
Area
Glycolytic Oxidative
Type 2B
Area Area Number Area Number
mm2 6 SEM (n) mm2 6 SEM % 6 SD mm2 6 SEM % 6 SD mm2 6 SEM (n)
wt 1,119 6 130 (3) 1,553 6 151 40 6 6 827 6 86 60 6 6 1,330 6 101 (3)
MMg 823 6 114 (3) NA ‡0 823 6 114 ‡100 ‡705 6 19 (4)
MMg 1 MId 728 6 84 (4) *840 6 116 *28 6 2 678 6 73 *72 6 2N D
MId 662 (1) 727 56 578 44 ND
EDL muscles of animals of each genotype were cryosectioned and reacted for NADH tetrazolium reductase or 2B MyHC. The cross sectional area of each of .200 fibers from the
midregion of each muscle was quantified, and the mean area and number of fibers for each category were determined. The means were then averaged to produce the values shown.
A statistically robust unbalanced ANOVA determined whether fiber populations varied in size depending on fiber type, individual animal, and genotype. Significant differences
were found between animals of the same genotype. After accounting for individual variation, significant differences from wild-type at the genotype level are represented by *(P ,
0.05), ‡(P , 0.001). Distinct metabolic fiber types differed significantly (P , 0.01) in fiber size in wild-type and MId, but not in MMg or MMg 1 MId.
Table III. Fiber Type Frequency (%) Is Unaffected by 
Myogenin Overexpression
Genotype n
Proportion of fibers of type
1 2A 2B 2X*
EDL
Wild-type 4 0.9 6 0.5 12 6 2 68 6 41 9
MMg 4 0.7  6 0.5 9 6 3 74 6 51 6
MMg 1 MId 3 1.2 6 0.6 14 6 4 67 6 71 8
Tibialis anterior (deep)
Wild-type 4 2 6 1 24 6 8 47 6 21 27
MMg 31   6 1 19 6 8 59 6 18 21
Tibialis anterior (superficial)
Wild-type 4 0 0 91 6 79
MMg 3 0 0 90  6 31 0
Soleus
Wild-type 7 55  6 6 51 6 30 0
MMg 3 60  6 1 41 6 40 0
MMg 1 MId 4 57 6 6 49 6 50 0
Serial cryostat sections of muscles from MMg, MMg 1 MId, and control wild-type lit-
termates were stained with A4.840 (slow, 1), A4.74 (2A), and BF-F3 (2B). Fiber num-
bers (6 SEM) in whole cross sections were counted and scored as positive or negative
for each antibody. *2X fiber frequencies are calculated assuming type 1 1 2A 1 2B 1
2X 5 100%, and are shown for comparison. In soleus, a few fibers express both slow
and 2A MyHC. MId mice were not analyzed because the small size of fibers in the an-
imals made accurate counting difficult. Most detailed analysis was performed on EDL
and soleus in which all fibers in the muscles were scored. For other muscles, a repre-
sentative field containing z250–300 fibers was scored with each antibody in a similar
area at approximately the same proximo-distal level within the leg, as judged by inde-
pendent anatomical markers.The Journal of Cell Biology, Volume 145, 1999 640
Hickner, 1994; Henriksson, 1995), and such changes are
thought to be a prerequisite for the increased muscular fa-
tigue-resistance obtained by training. It has been observed
previously that myogenin is more highly expressed in re-
gions with high oxidative capacity and mitochondrial con-
tent than in glycolytic muscles, in both rodents and fish
(Hughes et al., 1993b; Voytik et al., 1993; Rescan et al.,
1995). Hence, the present findings suggest that myogenin
might somehow be involved in gene regulation during fi-
ber type differentiation or adaptation to different training
states.
Regulation of Muscle Fiber Type
Although mechanical stretch and hormones also seem to
play a role, it is generally thought that physical activity
regulates muscle gene expression through electrical activ-
ity (for review see Gundersen, 1998). Myogenin expres-
sion is strongly regulated by activity (Duclert et al., 1991;
Eftimie et al., 1991; Witzemann and Sakmann, 1991; Buo-
nanno et al., 1992; Neville et al., 1992; Merlie et al., 1994),
and thought to be involved in the development of dener-
vation supersensitivity for acetylcholine by directly trans-
activating the genes for the subunits of the acetylcholine
receptor (Piette et al., 1990; Gilmour et al., 1991; Jia et al.,
1992; Prody and Merlie, 1992; Simon and Burden, 1993;
Dürr et al., 1994). Although it is tempting to draw parallels
between activity regulation of acetylcholine receptor and
activity regulation of metabolic properties, there are im-
portant differences. For example, denervation only has
small and variable effects on metabolic enzymes (data not
shown; Gundersen et al., 1988) despite leading to a strong
upregulation of all myogenic factors, including myogenin,
and having dramatic effects on acetylcholine receptor ex-
pression. Upregulation of myogenin alone in MMg mice,
on the other hand, leads to decline of MyoD and MRF4
mRNAs, and only a mild upregulation of the acetylcholine
receptor (Gundersen et al., 1995), but has strong effects on
metabolic enzymes. It adds to the complexity of this sys-
tem that myogenic factors of the helix-loop-helix family
are thought to work as heterodimers with E proteins
(Weintraub et al., 1991), that may themselves vary be-
tween tissues (Hu et al., 1992). On the basis of correlations
between myogenic factors and MyHC expression, it was
previously suggested that the myogenin/MyoD ratio might
regulate fiber phenotype (Hughes et al., 1993b). The
present work seems to support this idea since manipula-
tion of myogenin expression, which leads to a reciprocal
downregulation of MyoD (Gundersen et al., 1995), causes
an increase in oxidative metabolism in muscle fibers. The
correlations observed previously between MyHC and
myogenic factors could be accounted for by a relationship
to metabolic properties, because slow MyHC expressing
fibers are oxidative and fast 2B fibers are glycolytic. Our
data support the conclusion drawn from studies on effects
of moderate endurance training: oxidative enzyme activity
and MyHC type can be regulated independently (see
Kiens et al., 1993; Schluter and Fitts, 1994). On the other
hand, the finding that myogenin also had an effect on gly-
colytic enzymes without accompanying change in MyHC
contrasts with training studies in which glycolytic enzyme
changes were observed only after more extensive training
or electrical stimulation, and so were thought to parallel
changes in MyHC fiber type (Henriksson and Hickner,
1994). Our data suggest that even changes in glycolytic en-
zymes can be uncoupled from alterations in MyHC fiber
type.
Nevertheless, we cannot exclude the possibility that
myogenin is involved in MyHC fiber type conversions un-
der different conditions than those existing in surviving
MMg mice. The absence of MyHC changes could be re-
lated to the level of myogenin expressed, or perhaps to a
mechanism compensating for persistent artificial high lev-
els of myogenin in MMg animals. A compensatory mecha-
nism might be suspected because, as described previously,
only a minority of the mice overexpressing myogenin sur-
vive (Gundersen et al., 1995). It is notable that myoD null
mice also show increased neonatal death (Rudnicki et al.,
1992), and that the surviving myoD mutants have only
small changes in MyHC phenotype (Hughes et al., 1997).
While we prefer a model where myogenin is a link in the
pathway between activity and muscle phenotype, we can-
not exclude that the overexpression of myogenin in itself
influences activity. Although the animals appeared to
move normally, one can speculate that myogenin might
have impaired neuromuscular transmission. Due to the
high safety factor in neuromuscular synapses, impairment
of transmission would have to be major, and more impor-
tantly, reduced levels of activity would tend to induce
shifts in metabolism to the opposite direction of the one
observed, i.e., from oxidative to glycolytic. On the other
hand, the shift towards oxidative metabolism could be ex-
plained if the myogenin overexpression animals had
higher activity levels than wild-type animals. Increased cell
autonomous fibrillatory activity such as observed in dener-
vated muscles (Purves and Sakmann, 1974) cannot be ex-
cluded. Alternatively, increased activity could be triggered
from the CNS, e.g., caused by ectopic transgene expres-
sion. However, when the same expression system was cou-
pled to the reporter chloramphenicol acetyltransferase
(CAT), which provides a sensitive assay for detection of
expression, CAT activity was not found in the brain or any
other nonmuscle tissue (Rosenthal et al., 1989).
Intracellular Pathways for Determination of Muscle 
Fiber Type
All the oxidative enzymes measured are mitochondrial en-
zymes, and all were increased in MMg mice. However, AK
activity did not change, even though two of the three
forms of AK are nuclearly encoded proteins located in mi-
tochondria (Nobumoto et al., 1998). The distinct changes,
in particular mitochondrial enzymes, are similar to the
changes observed after endurance training, and sug-
gest not only an increase in mitochondria, but also an al-
teration in mitochondrial composition (Holloszy, 1988).
NADH tetrazolium reductase and SDH activities of the
electron transport chain increased, indicating coordinated
upregulation of mitochondrial proteins encoded by both
nuclear and mitochondrial genes. Moreover, NADH-TR
and SDH staining patterns gave the impression of an in-
crease in number and distribution of mitochondria, sup-
porting the conclusion that an alteration in number and
makeup of mitochondria is promoted by myogenin over-Hughes et al. Myogenin and Muscle Metabolism 641
expression. The pathway connecting myogenin to changes
in mitochondrial content in the MMg mice is unknown. In
other systems, mitochondrial activity is thought to be at
least partly mediated through transcriptional regulation,
but the mechanisms governing the concerted expression of
several nuclear and mitochondrial encoded genes for mi-
tochondrial proteins are still not well understood (Scar-
pulla, 1997). A possible effect of myogenin on the genes
for metabolic enzymes could be direct, by binding to the
promoter of such genes, or indirect, through altering pro-
cesses that normally regulate mitochondrial biogenesis
and cell metabolic status. In a variety of mammalian cell
types, recent studies implicate nuclear respiratory factor 1
(NRF-1) in nuclear synthesis of both RNAs encoding sev-
eral mitochondrial proteins and in genes involved in mito-
chondrial DNA replication (C.A. Virbasius et al., 1993;
J.V. Virbasius et al., 1993; Virbasius and Scarpulla, 1994;
Xia et al., 1997). In cardiac myocytes, NRF-1 expression is
induced by electrical activity by an unknown mechanism
(Xia et al., 1997). Although myogenic factors are not ex-
pressed in heart, our data raise the possibility that myoge-
nin could serve as a link between activity and NRF-1–reg-
ulated mitochondrial biogenesis in skeletal muscle.
Several promoters of metabolic enzyme genes contain
the consensus sequence for the binding site of helix-loop-
helix transcription factors (E-box), and in genes encoding
muscle/heart-specific forms of the cytochrome c oxidase
subunits VIII and VIa, it has been shown that an intact
E-box is required for efficient tissue-specific transcription
(Wan and Moreadith, 1995; Lenka et al., 1996). For the
VIII subunit, negative effects of Id-1 were also demon-
strated, strengthening the idea that helix-loop-helix pro-
teins are important in regulating this gene. The VIa sub-
unit required a MEF-2 site, in addition to the E-box, so
myogenic factors might also interact indirectly through
this sequence (Molkentin et al., 1995). The promoters for
several glycolytic enzymes also contain E-boxes, but in
these cases the E-box was found unnecessary for muscle-
specific expression. It is, however, still possible that myo-
genic factors act indirectly on these promoters (Molkentin
et al., 1995), since MEF-2 sites are important for muscle-
specific expression (Nakatsuji et al., 1992; Hidaka et al.,
1993; Feo et al., 1995; Froman et al., 1998). Besides, even if
myogenic factors might not be required for tissue-specific
expression, such factors may still regulate fiber type- or ac-
tivity-dependent expression. Moreover, few studies have
addressed the possibility that myogenic factors could act
as transcriptional suppressors, rather than activators (e.g.,
of glycolytic enzymes).
In conclusion, our data raise the possibility that skeletal
muscle myogenin, regulated by electrical activity, brings
about metabolic changes either through direct effects on
genes coding for muscle-specific mitochondrial and cyto-
plasmic enzymes, and/or indirectly on more ubiquitous mi-
tochondrial genes by enhancing expression of master regu-
lators of mitochondrial biogenesis, like NRF-1. Recently,
it has been reported that cyclosporin A can alter muscle fi-
ber type, possibly through effects of the calcium-activated
protein phosphatase calcineurin on the NFAT transcrip-
tion factors (Chin et al., 1998). The relationship of the re-
sults presented here to the effect of cyclosporin A is cur-
rently unclear. However, it would not be surprising if
several distinct groups of transcription factors were capa-
ble of modulating different aspects of muscle fiber type.
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